Viewing nowCombinationAlavix Tablets
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
KMS Pharmaceutical Co., Ltd.

MFDS item code 201800217 · Approved 2018.01.16
Treatment of acid-related disorders (e.g., ulcers and Zollinger-Ellison syndrome); prevention of Mendelson syndrome
This medication is used to treat ulcers occurring in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also helpful in preventing ulcers that may arise post-surgery and in treating gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drugs (NSAIDs). It may be administered before anesthesia to prevent Mendelson's syndrome. Therefore, it is used effectively to improve various gastric-related diseases and symptoms.
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when this medicine is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drug treatment usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. The dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets 3 times daily as the initial dose, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients undergoing dialysis treatment or in those with renal function issues. Additionally, it should not be administered to patients who have had allergic reactions to this medication or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, women who are pregnant or may become pregnant, premature infants and neonates, and patients on potassium-restricted diets. Use with caution in patients with poor liver function, a history of drug allergies, the elderly, patients with renal dysfunction history, and those taking nonsteroidal anti-inflammatory drugs. It may particularly hide symptoms of stomach cancer, so patients with gastric ulcers or middle-aged individuals who have recently experienced new dyspeptic symptoms should confirm whether it is malignant before treatment. Patients with Helicobacter pylori in gastric or duodenal ulcers require eradication therapy, and severe patients in intensive care units or those with hypophosphatemia also need caution. This medication may rarely cause severe allergic reactions or skin rashes, reduced blood cell counts, liver function abnormalities, arrhythmias, gastrointestinal disorders, neurological disorders, muscle pain, alopecia, and other various side effects, so if any adverse symptoms occur, the medication should be stopped immediately and the physician should be consulted. Avoid long-term use without medical supervision and consider switching to another medication if there is no therapeutic effect. The elderly, patients with chronic lung diseases, diabetes, and immunocompromised patients may have an increased risk of pneumonia, so caution is advised. If you feel dizziness or drowsiness while taking this medication, it is advisable to avoid driving or operating dangerous machinery. Additionally, this medication may interact with other drugs, so it is particularly important to consult a healthcare professional when taking anticoagulants, certain antibiotics, anticonvulsants, etc. It is safest for pregnant or breastfeeding women to avoid using this medication, and its safety in children has not been established, so it is preferable to avoid use in pediatric patients. This medication may affect test results, so reference should be made during examinations, and in cases of overdose, emergency measures such as inducing vomiting or gastric lavage should be taken. Finally, this medication reduces gastric acid secretion, which can promote bacterial growth in the stomach, and long-term use may require ophthalmologic examination for eye health.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air ingress and kept at a temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its efficacy and prevents degradation.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
KMS Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.